NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Yabang Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+3 more ↓
68%
Finnrick rating
#341 of 500 ranked vendors
27 of 36 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Yabang Peptide's Purity focus record is strongest in GHK-Cu, with TB-500 also clean but sparse, while Retatrutide and Tirzepatide are more volatile. Recent testing supports recency, but the trajectory is uneven: Retatrutide has purity/fill misses, Tirzepatide has sharp purity swings, and BPC-157, GHK-Cu, and TB-500 remain thin or batch-limited.

methodology →
vendor intelligence report
Vendor Intelligence Report: Yabang Peptide

Corporate/B2B records and the domain-certificate trail tell a shorter story than Yabang’s advertised history. The report maps the trading-company identity, template-site residue, nonfunctional social links, and buyer reports around WhatsApp sales, payment holds, and slow shipping.

21 pages6 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
88%
4
2
Retatrutide
$0.75
75%
16
3
Tirzepatide
$0.40
74%
9
4
BPC-157
$0.80
50%
4
5
TB-500
$1.30
48%
3
6
CJC-1295
$1.60
-
0
7
GLOW
$0.21
-
0
8
HGH
$0.50
-
0
9
Ipamorelin
$1.00
-
0
10
NAD+
$0.50
-
0
11
Tesamorelin
$1.96
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Oct 2025: 78%14 Oct 2025: 79%14 Oct 2025: 80%14 Oct 2025: 82%14 Oct 2025: 78%14 Oct 2025: 74%17 Nov 2025: 75%17 Nov 2025: 73%17 Nov 2025: 73%16 Dec 2025: 63%6 Jan 2026: 70%9 Jan 2026: 62%22 Jan 2026: 63%7 Mar 2026: 63%7 Mar 2026: 65%7 Mar 2026: 68%7 Mar 2026: 68%5 May 2026: 69%5 May 2026: 69%8 May 2026: 70%8 May 2026: 69%27 May 2026: 69%2 Jun 2026: 69%16 Jun 2026: 69%1 Jul 2026: 69%1 Jul 2026: 69%1 Jul 2026: 69%1 Jul 2026: 69%1 Jul 2026: 70%13 Jul 2026: 69%14 Jul 2026: 69%4 Aug 2026: 69%9 Sep 2026: 69%9 Sep 2026: 68%16 Sep 2026: 68%10 Nov 2026: 68%17 Nov 2026: current 68%78%63%68%Oct 25Nov 26
Peptide testing

Ordered peptides from Yabang Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Yabang Peptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
10 Nov 2026
Pass
GHK-Cu
lab nameView COA
16 Sep 2026
Pass
TB-500
lab nameView COA
9 Sep 2026
Fail
Retatrutide
lab nameView COA
9 Sep 2026
Fail
BPC-157
lab nameView COA
4 Aug 2026
Pass
Retatrutide
lab nameView COA
14 Jul 2026
Fail
BPC-157
lab nameView COA
13 Jul 2026
Fail
Retatrutide
lab nameView COA
1 Jul 2026
Pass
Retatrutide
lab nameView COA
1 Jul 2026
Pass
GHK-Cu
lab nameView COA
1 Jul 2026
Pass
Retatrutide
lab nameView COA
1-10 of 36

About Yabang Peptide test results from Finnrick

Yabang Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 36 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Yabang Peptide peptides in this dataset are BPC-157 (4 tests), GHK-Cu (4 tests) and Retatrutide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 36 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Yabang Peptide? Mail in a sample (US only) and let us test it.

Test my supply